PatternsRadar
Sign in

TAKETake Solutions Limited

NSE
Full chart
11.55INR-0.51 (-4.23%)Close · 6 Oct 2026
11 Aug 2026Last results
HealthcareSector
Healthcare ServicesIndustry
₹171 CrMarket cap
13.3P/E (TTM)
73.4%Delivery

Filings & corporate actions

73 results filed
CSV
Next results · Q2 FY27
Expected 27 Oct 2026 – 23 Jan 2027
Estimate: filed 27–115 days after quarter end, last 5 times
Dividend
₹0.40 per share · last 1 Aug 2019
2026
  • 11 AugresultsResults · Q1 FY27 · consolidated and standalone+1.2%NSE
  • 20 JulshareholdingShareholding · 30 Jun 2026+4.9%NSE
  • 20 MayresultsResults · Q4 FY26 · consolidated and standalone+5.0%NSE
  • 21 AprshareholdingShareholding · 31 Mar 2026-2.0%NSE
  • 14 FebresultsResults · Q3 FY26 · consolidated and standalone-4.4%NSE
  • 21 JanshareholdingShareholding · 31 Dec 2025-3.3%NSE

Reaction to results · all yearsrose on day 0 in 21 of 72 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY2711 Aug 2026+1.2%-1.5%-31.2%1.9×
Q4 FY2620 May 2026+5.0%+14.9%+12.1%1.1×
Q3 FY2614 Feb 2026-4.4%-4.3%-18.8%2.0×
Q2 FY2627 Oct 2025-5.0%-8.8%+23.0%1.6×
Q1 FY267 Jul 2025+5.0%-8.3%-11.3%2.9×
Q4 FY2530 May 2025-1.7%+0.5%+3.0%0.6×
Q3 FY2513 Feb 2025-3.6%+1.7%-26.6%0.4×
Q1 FY2523 Jan 2025-3.7%-21.2%-30.0%1.3×
Q2 FY2523 Jan 2025-3.7%-21.2%-30.0%1.3×
Q4 FY2431 May 2024-1.5%+5.6%+2.4%1.1×
Q3 FY2413 Feb 2024+4.9%-2.1%-25.4%0.3×
Q2 FY249 Nov 2023-4.3%-3.0%+5.3%2.1×
Q1 FY2415 Aug 2023-2.7%-0.8%+14.6%0.9×
Q4 FY2330 May 2023-0.9%+3.1%-1.1%0.2×
Q3 FY2315 Feb 2023-0.5%-10.2%-19.4%1.5×
Q2 FY238 Dec 2022-5.2%-7.6%-13.2%1.8×
Q1 FY2319 Oct 2022-3.7%-7.2%-8.2%1.0×
Q4 FY2228 May 2022-0.9%+2.8%-1.9%0.9×
Q3 FY229 Feb 2022-4.2%-8.6%-1.4%1.7×
Q2 FY2213 Nov 2021-2.1%-8.4%+1.0%0.9×
Q1 FY2212 Aug 2021-0.6%-20.5%-11.6%0.5×
Q4 FY2125 Jun 2021-1.9%+2.9%-5.3%0.8×
Q3 FY2112 Feb 2021+0.2%-2.0%-3.4%0.6×
Q2 FY2113 Nov 2020-3.4%-3.3%+9.4%4.5×
Q1 FY2115 Sept 2020-6.8%-12.5%-11.2%1.3×
Q4 FY2012 Jun 2020-4.9%-13.1%-28.9%0.3×
Q3 FY2013 Feb 2020+6.8%-0.7%-51.5%3.6×
Q2 FY206 Nov 2019-3.3%-7.6%-15.8%0.8×
Q1 FY208 Aug 2019-4.1%-4.0%+20.8%1.7×
Q4 FY1916 May 2019-0.8%+3.6%-7.9%0.9×
Q3 FY1928 Feb 2019+1.5%+7.0%+13.8%0.4×
Q2 FY1912 Nov 2018+2.5%-13.3%-15.4%1.3×
Q1 FY1928 Aug 2018-3.1%-1.1%-21.0%0.5×
Q4 FY1819 Jun 2018-3.1%-15.4%-8.8%1.1×
Q3 FY1822 Feb 2018+1.0%-0.1%-3.2%0.7×
Q2 FY189 Nov 2017-1.8%+2.7%+1.4%0.4×
Q1 FY1823 Aug 2017-0.4%+5.1%+18.2%1.8×
Q4 FY1730 May 2017+6.1%+22.7%+28.5%1.5×
Q3 FY173 Feb 2017+1.0%+3.1%+5.0%1.7×
Q2 FY178 Nov 20160.0%-6.2%-6.9%0.5×
Q1 FY1713 Aug 2016-0.7%-6.5%-6.5%1.0×
Q4 FY1616 May 2016+2.9%-2.2%+13.5%1.4×
Q3 FY169 Feb 2016-1.8%-6.6%+7.0%0.7×
Q2 FY1616 Nov 2015-0.4%+4.9%-4.8%1.2×
Q1 FY1610 Aug 2015+0.9%+7.5%-24.5%0.6×
Q4 FY1520 May 2015-0.7%-10.1%-20.5%0.6×
Q3 FY159 Feb 2015-1.4%+14.2%+35.4%0.4×
Q2 FY1522 Nov 2014+1.6%+39.9%+33.4%1.1×
Q1 FY1512 Aug 2014-2.9%+1.2%+14.9%0.4×
Q4 FY1420 May 2014-1.1%+10.7%+12.4%3.4×
Q3 FY141 Feb 2014-6.2%-8.5%-4.3%0.5×
Q2 FY1415 Nov 20130.0%+7.6%+18.0%0.6×
Q1 FY142 Aug 2013-3.8%-1.7%-9.5%1.4×
Q4 FY134 Jun 2013-0.2%+8.1%+3.8%0.8×
Q3 FY1319 Feb 2013+0.4%-3.6%-10.0%0.9×
Q2 FY139 Nov 2012-4.8%-9.9%-8.9%1.4×
Q1 FY1314 Aug 2012-2.5%-0.7%+8.3%0.4×
Q4 FY1229 May 2012-3.5%+5.8%-3.3%5.0×
Q3 FY123 Feb 2012+7.9%+10.0%+9.0%6.3×
Q2 FY1228 Oct 2011-3.9%-13.4%-20.5%3.1×
Q1 FY121 Aug 2011-0.4%-8.8%-17.4%3.0×
Q3 FY1128 Jan 2011-3.8%-1.6%-4.1%1.3×
Q2 FY1129 Oct 2010-1.3%+0.6%-20.9%2.7×
Q1 FY1130 Jul 2010+5.5%+30.2%+19.8%6.3×
Q3 FY1030 Jan 2010+2.4%-1.8%-11.4%0.3×
Q2 FY104 Nov 2009+1.3%+5.0%+0.5%0.8×
Q1 FY1031 Jul 2009+1.1%-1.9%+14.1%0.8×
Q3 FY092 Feb 2009-5.4%-4.8%-13.2%2.5×
Q2 FY0924 Oct 2008-14.0%+39.7%-21.2%1.2×
Q1 FY0925 Jul 2008-3.7%-4.6%+9.2%0.7×
Q3 FY0824 Jan 2008-1.7%-2.4%-3.3%0.8×
Q2 FY0829 Oct 2007+1.2%+1.2%-12.5%0.2×
Average-1.2%-0.5%-3.7%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY—
Profit YoY—
Interest cost YoY-89.4%
Revenue QoQ-43.9%
Profit QoQ-75.6%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+32.5%-18.0%-36.0%-36.5%-39.9%—
Profit——————

Key data

CSV
Open11.86
Day range11.51 – 12.49
52-week range10.63 – 50.14
From 52w high-77.0%
RSI (14)24.3
ATR (14)0.92
Volume5.78L
Avg volume (20D)3.86L
Rel volume1.50×
Volatility (1Y)53.7%
Turnover₹66.7L
SMA 50 / 20018.25 / 31.83

Delivery percentage

Latest · 6 Oct 202673.4%
20-day avg77.9%
1-year avg96.3%
Percentile (own history)67th
Range15.9–100.0%
Sessions1,731

Over the last 20 sessions TAKE settled 77.9% of its traded quantity, which is unusually high for an NSE equity. Its one-year average is 96.3%, so recent sessions are running 18.3 points lower than usual. The latest session ranks higher than 67% of the 1,731 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryHealthcare Research Analytics & Technology
PeersAPOLLOHOSPMAXHEALTHFORTISYATHARTHASTERDMMANIPALHOS

Performance returns

CSV
1D1W1M3M6M1Y
Price-4.23%-21.64%-12.30%-53.39%-71.97%+10.74%

Valuation

CSV
Market cap₹171 Cr
P/E (TTM)13.3
EPS (TTM)0.87
Shares outstanding14.79Cr
Listed27 Aug 2007

Ownership

CSV
Promoter0.00%
Promoter Δ QoQ0.00 pp
Public100.00%
FII0.21%
DII0.00%
Pledged0.00%

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)0.00.054.230.4
YoY chg————
Net profit (₹ Cr)6.31.14.41.1
YoY chg—-97.7%——
Net margin——8.0%3.5%
EPS0.430.070.290.07

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 0.00% · public 100.00%
30 Sept 2021: promoter 53.41%31 Dec 2021: promoter 53.41%31 Mar 2022: promoter 53.41%30 Jun 2022: promoter 53.41%30 Sept 2022: promoter 53.41%31 Dec 2022: promoter 53.41%31 Mar 2023: promoter 53.41%30 Jun 2023: promoter 53.41%30 Sept 2023: promoter 53.41%31 Dec 2023: promoter 53.41%31 Mar 2024: promoter 53.41%30 Jun 2024: promoter 53.41%30 Sept 2024: promoter 53.41%31 Dec 2024: promoter 53.41%31 Mar 2025: promoter 53.41%30 Jun 2025: promoter 53.34%30 Sept 2025: promoter 5.19%31 Dec 2025: promoter 0.00%31 Mar 2026: promoter 0.00%30 Jun 2026: promoter 0.00%
2021-092026-06
  • Promoter
  • Public and others
Promoter
0.00%
Public
100.00%
Promoter change
0.00 pp
Filed
20 Jul 2026
FII
0.21%
DII
0.00%
Promoter pledged
0.00%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q2 FY24Q3 FY24Q4 FY24AQ1 FY25AQ2 FY25AQ3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27
Revenue from operations18.116.913.20.00.00.00.00.00.00.054.230.4
Other income0.11.10.10.00.08.51.70.00.01.55.21.3
Total income18.217.913.30.00.08.51.70.00.01.559.431.7
Total expenses19.818.931.22.71.73.61.41.00.50.455.030.6
└ Finance costs1.41.31.20.50.50.70.20.20.20.00.00.0
└ Depreciation2.21.91.60.00.00.00.00.00.00.00.00.0
Profit before tax(1.6)(1.0)(110.8)(2.7)(1.7)4.90.3(0.9)(0.5)1.14.41.1
Tax expense(0.1)1.2(0.1)0.1(0.1)0.00.00.00.20.00.00.0
Net profit(1.5)(2.1)(110.6)(3.7)(1.6)47.7(4.9)(0.9)6.31.14.41.1
EPS-0.11-0.15-7.56-0.26-0.113.26-0.33-0.060.430.070.290.07
Net margin-8.56%-12.68%-837.60%———————8.05%3.50%
PBT margin-8.90%-5.66%-838.73%———————8.05%3.50%
Tax rate—————0.00%0.00%——0.00%0.00%0.00%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 11 Aug 2026.

TAKE at a glance

  • TAKE closed at ₹11.55 on 6 Oct 2026, -4.23% on the day, +10.7% over one year, 77.0% below its 52-week high of ₹50.14.
  • Delivery was 73.4% of traded quantity on 6 Oct 2026, the 67th percentile of its own 1,731 sessions with a reading (20-session average 77.9%, 1-year average 96.3%).
  • Market capitalisation is ₹171 crore at a trailing P/E of 13.3 (trailing EPS ₹0.87).
  • Q1 FY27 results (consolidated, filed 11 Aug 2026): revenue ₹30 crore, net profit ₹1 crore; the price moved +1.2% on the first session after.
  • Promoters held 0.00% at 30 Jun 2026, unchanged on the previous filing.
  • Q2 FY27 results are expected between 27 Oct 2026 and 23 Jan 2027, going by past filing dates — an estimate, not an announcement.

About

CSV
Macro sectorHealthcare
Basic industryHealthcare Research Analytics & Technology
ISININE142I01023
SeriesEQ
Listed27 Aug 2007
History from27 Aug 2007
Sessions4,731

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Healthcare Services

CSV

All Healthcare Services stocks on the NSEAll Healthcare stocks on the NSE